var useSSL = ‘https:’ == document.location.protocol;
var src = (useSSL ? ‘https:’ : ‘http:’) +
Welcome to Medical News Today
Healthline Media, Inc. would like to process and share personal data (e.g., mobile ad id) and data about your use of our site (e.g., content interests) with our third party partners (see a current list) using cookies and similar automatic collection tools in order to a) personalize content and/or offers on our site or other sites, b) communicate with you upon request, and/or c) for additional reasons upon notice and, when applicable, with your consent.
Healthline Media, Inc. is based in and operates this site from the United States. Any data you provide will be primarily stored and processed in the United States, pursuant to the laws of the United States, which may provide lesser privacy protections than European Economic Area countries.
A new study concludes that vitamin D might help slow bowel cancer progression.
Dr. Kimmie Ng, director of clinical research at Dana-Farber’s Gastrointestinal Cancer Treatment Center in Boston, MA, says that the results of the trial are promising and could lead to new treatment possibilities in the future.
In the SUNSHINE trial, the results of which featured in the journal JAMA, the researchers recruited 139 people with previously untreated metastatic colorectal cancer and split them into two groups — high-dose vitamin D and low-dose vitamin D.
The high-dose group took 8,000 international units (IU) of vitamin D each day for 14 days, before switching to 4,000 IU a day. The low-dose group took 400 IU each day for the entire duration of the study. Both groups also received standard chemotherapy during the trial.
The researchers observed that disease progression in the participants in the high-dose group stopped for an average of about 13 months, while those in the low-dose group experienced a delay in progression of close to 11 months.
Also, they discovered that the participants in the high-dose group were less likely to experience disease progression or death during a 22.9-month follow-up period.
“The results of our trial suggest an improved outcome for patients who received vitamin D supplementation, and we look forward to launching a larger trial to confirm these exciting and provocative findings,” noted Dr. Charles Fuchs, senior author of the study and director of the Yale Cancer Center in New Haven, CT.
Colorectal cancer basics and statistics
As its name implies, colorectal cancer begins in either the colon or the rectum. Although people can label cancer more specifically as colon cancer or rectal cancer, it is common to group them because they share similar features.
Most colorectal cancer begins as a growth, called a polyp, that appears on the lining of the colon or rectum, although not all polyps turn into cancer. When a healthcare professional finds a polyp during a colonoscopy, they usually remove it during the same procedure and test it.
Outside of skin cancers, colorectal cancer is the third most common cancer diagnosis in both men and women in the United States. The American Cancer Society estimate that there will be more than 100,000 new cases of colon cancer in 2019, and they also expect in excess of 44,000 new cases of rectal cancer.
Survival rates for this type of cancer have been increasing over the last several decades, in part due to screening that reveals polyps. The identification and subsequent removal of any polyps mean that they do not have the chance to turn into cancer.
Potential for a safe and accessible treatment
Before the SUNSHINE trial began, only 9 percent of the participants had sufficient levels of vitamin D. The team noted that only those in the large-dose group developed and maintained adequate levels during the study.
The body produces vitamin D as a result of sunlight on the skin and can also obtain it from a few dietary sources.
Dr. Ng said that the study results are very important because vitamin D is widely available, safe, and inexpensive. However, the authors also note that people should not take high doses outside the context of clinical research.
“To our knowledge, this study is the first completed randomized clinical trial of vitamin D supplementation for treatment of advanced or metastatic colorectal cancer.”
Dr. Kimmie Ng
The study also raises new questions. For instance, the scientists found that people who were obese were less likely to see the benefits of vitamin D, which was also the case for individuals whose tumors contained a mutated KRAS gene.
As the study only included 139 people, the scientists are keen to expand their investigation. The authors write that their findings “warrant further evaluation in a larger multicenter randomized clinical trial.”
Seven alternatives to a colonscopy
A colonoscopy is commonly used to detect colon cancer. It involves inserting a tube into the rectum with a tiny camera at the end. However, it can be costly and invasive, and some people might prefer an alternative, such as a blood test, a barium enema, or a stool test, among others. Learn more about the options here.
What you need to know about chemotherapy
Chemotherapy is a widespread and effective way of treating cancerous tissues in the body. Chemotherapy destroys cancer cells, but its side effects can be debilitating and hard to manage. Find out here all about chemotherapy and how it works and whether the positive results balance out with the negatives ones.
What are the different types of tumors?
A tumor is an abnormal mass of tissue that may be solid or fluid-filled. The size can vary extensively. Some tumors are not harmful, cannot spread, and rarely return once removed. Others are cancerous or have the potential to become so. In this article, learn how doctors tell the difference and what next steps may be.
Recommended related news
Source Article from https://www.medicalnewstoday.com/articles/324984.php